Philip Morris International Appoints Finance Leader Victoria Harker to Its Board of Directors
18 Setembro 2023 - 8:00AM
Business Wire
Philip Morris International Inc. (PMI) (NYSE: PM) announced
today that on September 13, 2023, its Board of Directors appointed
a new member, Ms. Victoria Harker, to serve on the Board of
Directors, effective January 1, 2024.
Victoria Harker is an experienced U.S. public-company Chief
Financial Officer, having served in the role with three different
companies, and she has been involved in significant corporate
transformations in the consumer, industrial and utility sectors for
over 25 years. She is a high-energy, action-oriented, strategic
executive, who has worked at a significant scale, most recently as
Executive Vice President and Chief Financial Officer of TEGNA Inc.,
a global media and digital communications company, a position she
will step down from effective December 31, 2023. Prior to this, she
served as Executive Vice President, Chief Financial Officer and
President, Global Business Services, of The AES Corporation, a
global power company. She has served as a non-executive member of
the boards of directors of two large and complex U.S. public
companies, Huntington Ingalls Industries and Xylem Inc., since the
time of their respective spin-offs. Ms. Harker also serves as the
audit committee chair for Huntington Ingalls Industries and as the
compensation committee chair for Xylem Inc. She is Vice Chair of
the State Council of Higher Education for Virginia, a member of the
University of Virginia Health System Board, and was previously a
member of the University of Virginia Board of Visitors.
André Calantzopoulos, PMI’s Executive Chairman, commended Ms.
Harker on the appointment, and said, “We are delighted to welcome
Victora to the PMI Board of Directors. Her broad finance and
business experience will further strengthen and diversify the
capabilities of our Board in successfully guiding our company
through its ambitious and highly promising journey towards a
smoke-free future and beyond.”
Philip Morris International: Delivering a Smoke-Free
Future
Philip Morris International (PMI) is a leading international
tobacco company working to deliver a smoke-free future and evolving
its portfolio for the long term to include products outside of the
tobacco and nicotine sector. The company’s current product
portfolio primarily consists of cigarettes and smoke-free products,
including heat-not-burn, vapor and oral nicotine products, which
are sold in markets outside the U.S. Since 2008, PMI has invested
more than USD 9 billion to develop, scientifically substantiate and
commercialize innovative smoke-free products for adults who would
otherwise continue to smoke, with the goal of completely ending the
sale of cigarettes. This includes the building of world-class
scientific assessment capabilities, notably in the areas of
pre-clinical systems toxicology, clinical and behavioral research,
as well as post-market studies. The U.S. Food and Drug
Administration (FDA) has authorized the marketing of versions of
PMI’s IQOS Platform 1 devices and consumables as Modified Risk
Tobacco Products (MRTPs), finding that exposure modification orders
for these products are appropriate to promote the public health. As
of June 30, 2022, excluding Russia and Ukraine, PMI's smoke-free
products were available for sale in 70 markets, and PMI estimates
that approximately 13.2 million adults around the world had already
switched to IQOS and stopped smoking. With a strong foundation and
significant expertise in life sciences, in February 2021 PMI
announced its ambition to expand into wellness and healthcare areas
and deliver innovative products and solutions that aim to address
unmet consumer and patient needs. For more information, please
visit www.pmi.com and www.pmiscience.com.
Forward-Looking and Cautionary Statements
This press release contains projections of future results and
goals and other forward-looking statements, including statements
regarding PMI’s strategy and business prospects. Achievement of
future results is subject to risks, uncertainties and inaccurate
assumptions. In the event that risks or uncertainties materialize,
or underlying assumptions prove inaccurate, actual results could
vary materially from those contained in such forward-looking
statements. Pursuant to the “safe harbor” provisions of the Private
Securities Litigation Reform Act of 1995, PMI is identifying
important factors that, individually or in the aggregate, could
cause actual results and outcomes to differ materially from those
contained in any forward-looking statements made by PMI.
PMI's business risks include: excise tax increases and
discriminatory tax structures; increasing marketing and regulatory
restrictions that could reduce our competitiveness, eliminate our
ability to communicate with adult consumers, or ban certain of our
products in certain markets or countries; health concerns relating
to the use of tobacco and other nicotine-containing products and
exposure to environmental tobacco smoke; litigation related to
tobacco use and intellectual property; intense competition; the
effects of global and individual country economic, regulatory and
political developments, natural disasters and conflicts; the impact
and consequences of Russia's invasion of Ukraine; changes in adult
smoker behavior; the impact of COVID-19 on PMI's business; lost
revenues as a result of counterfeiting, contraband and cross-border
purchases; governmental investigations; unfavorable currency
exchange rates and currency devaluations, and limitations on the
ability to repatriate funds; adverse changes in applicable
corporate tax laws; adverse changes in the cost, availability, and
quality of tobacco and other agricultural products and raw
materials, as well as components and materials for our electronic
devices; and the integrity of its information systems and
effectiveness of its data privacy policies. PMI's future
profitability may also be adversely affected should it be
unsuccessful in its attempts to produce and commercialize
reduced-risk products or if regulation or taxation do not
differentiate between such products and cigarettes; if it is unable
to successfully introduce new products, promote brand equity, enter
new markets or improve its margins through increased prices and
productivity gains; if it is unable to expand its brand portfolio
internally or through acquisitions and the development of strategic
business relationships; if it is unable to attract and retain the
best global talent, including women or diverse candidates; or if it
is unable to successfully integrate and realize the expected
benefits from recent transactions and acquisitions. Future results
are also subject to the lower predictability of our reduced-risk
product category's performance.
PMI is further subject to other risks detailed from time to time
in its publicly filed documents, including PMI's Annual Report on
Form 10-K for the fourth quarter and year ended December 31, 2022
and Quarterly Report on Form 10-Q for the second quarter ended June
30, 2023. PMI cautions that the foregoing list of important factors
is not a complete discussion of all potential risks and
uncertainties. PMI does not undertake to update any forward-looking
statement that it may make from time to time, except in the normal
course of its public disclosure obligations.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230918322409/en/
Philip Morris International David Fraser / Corey Henry T. +41 79
843 8603 / +1 (202) 679 7296 E. David.Fraser@pmi.com /
Corey.Henry@pmi.com
Philip Morris (NYSE:PM)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Philip Morris (NYSE:PM)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024